Evaluation of the efficacy of ombitasvir and paritaprevir with ritonavir for Japanese hepatitis C patients: a prospective study in real-life settings.
Not Applicable
Recruiting
- Conditions
- chronic hepatitis C
- Registration Number
- JPRN-UMIN000021276
- Lead Sponsor
- Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
decompensated cirrhosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virological response (SVR) at 12 week and 24 week after the end of treatment
- Secondary Outcome Measures
Name Time Method incidence rate of adverse events